<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Enrolled-Bill" dms-id="H64171712777F4FE3B3FE221D0FB7E9ED" public-private="public" key="H" bill-type="olc" stage-count="1"> 
<form> 
<distribution-code display="no">I</distribution-code> 
<congress>One Hundred Twelfth Congress of the United States of America</congress> <session>At the Second Session</session><enrolled-dateline>Begun and held at the City of Washington on Tuesday, the third day of January, two thousand and twelve</enrolled-dateline> 
<legis-num>H. R. 6433</legis-num> 
<current-chamber display="no"></current-chamber> 
<legis-type>AN ACT</legis-type> 
<official-title display="yes">To make corrections with respect to Food and Drug Administration user fees.</official-title> 
</form> 
<legis-body id="H975025E826324B2DA575FF18EAE106AC" style="OLC"> 
<section id="H98ABB0800CB64268A7B5856835CB7D3B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote>FDA User Fee Corrections Act of 2012</quote>.</text></section> 
<section id="HA69961DA243844E58ADE365F76A97C35"><enum>2.</enum><header>Corrections to FDA user fees</header> 
<subsection id="H29A93B58AE4F43FDB348B6DC3A1210E6"><enum>(a)</enum><text display-inline="yes-display-inline">Section 502(aa) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352(aa)) is amended by striking <quote>744A(a)(4)</quote> and inserting <quote>744B(a)(4)</quote>. </text></subsection> 
<subsection id="HF203DBEAEF914B5A96754921032E43CE"><enum>(b)</enum><text display-inline="yes-display-inline">Subchapter C of title VII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379f et seq.) is amended—</text> 
<paragraph id="H0416B3BE13FB4711AB6F1E6EDE4AA82C"><enum>(1)</enum><text display-inline="yes-display-inline">in section 738(i)(2)(A)(ii), by striking <quote>shall only be available</quote> and inserting <quote>shall be available</quote>;</text></paragraph> 
<paragraph id="HF15D63A867B14372988817BC18F8D4B8"><enum>(2)</enum><text display-inline="yes-display-inline">in sections 744B(a)(2)(E)(ii)(II), 744B(a)(3)(C)(ii)(III), 744B(a)(4)(D)(i)(II), and 744B(a)(4)(D)(ii)(II), by inserting <quote>for such year</quote> after <quote>obligation of fees</quote> each place it appears; and</text></paragraph> 
<paragraph id="H95857386FF1248A0A2D12EE10B835342"><enum>(3)</enum><text>in section 744B(i)(2)(C)—</text> 
<subparagraph id="H57F9B10528F14216A1069023B784AD98"><enum>(A)</enum><text>by inserting a comma after <quote>September 30, 2013</quote>; and</text></subparagraph> 
<subparagraph id="HC6F2ED20D2394D8DBAA6A319CCA9A8BA"><enum>(B)</enum><text>by striking the comma after <quote>for fiscal year 2013</quote>.</text></subparagraph></paragraph> </subsection> 
<subsection id="H0EBA749947EB42DFAA547DE1628FF98F"><enum>(c)</enum> 
<paragraph id="HFCFC26BF2DCA4D90834A38C16E011429" display-inline="yes-display-inline"><enum>(1)</enum><text display-inline="yes-display-inline">Notwithstanding section 744B(a)(2)(E)(ii) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–42(a)(2)(E)(ii)), the fee authorized under section 744B(a)(2) of such Act for fiscal year 2013 shall be due 30 calendar days after publication of the notice provided for in section 744B(a)(2)(C)(i) of such Act.</text></paragraph> 
<paragraph id="H90005EDCE31E488393DDCF836D370384" indent="up1"><enum>(2)</enum><text>Notwithstanding section 744B(a)(3)(C)(ii) of such Act, the fee authorized under section 744B(a)(3) of such Act for fiscal year 2013 shall be due on the later of—</text> 
<subparagraph id="HBD64503998504A9984E5FED5F06E1361"><enum>(A)</enum><text display-inline="yes-display-inline">the date of submission of the abbreviated new drug application or prior approval supplement for which such fee applies; or</text></subparagraph> 
<subparagraph id="H8546EEFD5FEE49B59B66B851ABAB46F6"><enum>(B)</enum><text display-inline="yes-display-inline">30 calendar days after publication of the notice referred to in section 744B(a)(3)(B)(i) of such Act.</text></subparagraph></paragraph> 
<paragraph id="HAA8DD65232CE44359A12FC8C24DD03BA" indent="up1"><enum>(3)</enum><text display-inline="yes-display-inline">Notwithstanding section 744B(a)(4)(D)(i) of such Act, the fee authorized under section 744B(a)(4) of such Act for fiscal year 2013 shall be due not later than 45 days after the publication of the notice under section 744B(a)(4)(C)(i) of such Act.</text> </paragraph> </subsection></section> 
</legis-body> <attestation><attestation-group><role>Speaker of the House of Representatives.</role></attestation-group><attestation-group><role>Vice President of the United States and President of the Senate.</role></attestation-group></attestation>
</bill> 
